Single- and Multiple-Dose Pharmacokinetics of Levovirin Valinate Hydrochloride (R1518) in Healthy Volunteers
- 1 May 2005
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 45 (5) , 578-596
- https://doi.org/10.1177/0091270005274861
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Design of Ester Prodrugs to Enhance Oral Absorption of Poorly Permeable Compounds: Challenges to the Discovery ScientistCurrent Drug Metabolism, 2003
- Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virusExpert Opinion on Pharmacotherapy, 2003
- Peginterferon-??-2a (40kD) Plus RibavirinDrugs, 2003
- Absorption, pharmacokinetics and excretion of levovirin in rats, dogs and cynomolgus monkeys.Journal of Antimicrobial Chemotherapy, 2002
- Specific, sensitive and accurate LC–MS/MS method for the measurement of levovirin in rat and monkey plasmaJournal of Pharmaceutical and Biomedical Analysis, 2002
- Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis CAlimentary Pharmacology & Therapeutics, 2002
- ValaciclovirDrugs, 2000
- Pharmacokinetics of Valganciclovir and Ganciclovir Following Multiple Oral Dosages of Valganciclovir in HIV- and CMV-Seropositive VolunteersClinical Pharmacokinetics, 1999
- Valaciclovir (BW256U87): The L-valyl ester of acyclovirJournal of Medical Virology, 1993
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976